Left Ventricular Assist Devices (LVAD) arşivleri - Aventin Health https://aventinhealth.com/en/ Cardiac Rhythm Management, Heart Failure Thu, 13 Jan 2022 12:08:35 +0000 en-US hourly 1 https://wordpress.org/?v=5.9.2 https://aventinhealth.com/wp-content/uploads/2022/01/cropped-aventin-favicon-02-32x32.png Left Ventricular Assist Devices (LVAD) arşivleri - Aventin Health https://aventinhealth.com/en/ 32 32 HeartMate 3™ https://aventinhealth.com/en/urunler/abbott-products/cardiovascular-products/left-ventricular-assist-devices-lvad/heartmate-3/ Thu, 13 Jan 2022 12:08:35 +0000 https://aventinhealth.com/urunler/uncategorized/heartmate-3/ The HeartMate 3™ Left Ventricular Assist Device provides short- and long-term mechanical circulatory support (eg. The HeartMate 3 LVAD with Full MagLev™ Flow Technology provides unprecedented* survival and safety results at 2 years as demonstrated in the MOMENTUM 3 Trial.

HeartMate 3™ yazısı ilk önce Aventin Health üzerinde ortaya çıktı.

]]>

The HeartMate 3™ LVAD with Full MagLev™ Flow Technology has significantly advanced the field of LVAD therapy, setting the standard with innovation and outstanding clinical results that make a meaningful difference in the lives of your patients.

This innovation includes Full MagLev Flow Technology that maintains gentle blood processing to minimize complications and adverse events related to hemocompatibility.

The HeartMate 3 LVAD is used for patients with advanced heart failure who need short or long-term mechanical circulatory support.

RESULTS POSSIBLE WITH FULL MAGLEV FLOW TECHNOLOGY

Full MagLev Flow Technology maintains gentle blood processing to minimize complications and adverse events related to hemocompatibility.

Fully levitated, self-centering rotor that does not require hydrodynamic or mechanical bearings

Large, consistent blood flow pathways to reduce shear stress3

Intrinsic pulsatility to reduce stasis and minimize thrombus3,4

  • Fully levitated, self-centering rotor that does not require hydrodynamic or mechanical bearings
  • Large, consistent blood flow pathways to reduce shear stress
  • Internal pulsatility to reduce stasis and minimize thrombus
Cut across view of the HeartMate 3 Maglev Pump

HeartMate 3™ yazısı ilk önce Aventin Health üzerinde ortaya çıktı.

]]> HeartMate 2™ https://aventinhealth.com/en/urunler/abbott-products/cardiovascular-products/left-ventricular-assist-devices-lvad/heartmate-2/ Thu, 13 Jan 2022 11:59:13 +0000 https://aventinhealth.com/urunler/uncategorized/heartmate-2/ The HeartMate II™ LVAD is designed to provide short-term or long-term circulatory support for patients with advanced heart failure and is indicated in the United States for both target therapy and bridge to transplantation. Backed by over 10 years of data, the HeartMate II LVAD is the most widely used and most extensively studied LVAD in the world, implanted in more than 27,000 patients worldwide.

HeartMate 2™ yazısı ilk önce Aventin Health üzerinde ortaya çıktı.

]]>

Proven Results for Long-Term Support

The HeartMate II™ Left Ventricular Assist Device (LVAD) provides short- or long-term circulatory support for patients with moderate to severe heart failure. This small, quiet pump has a simple design – with only one moving part – and can deliver blood flow equivalent to that of a healthy heart.

UNIQUE REAL WORLD EXPERIENCE
More than 27,000 patients implanted with a HeartMate II LVAD

HeartMate II LVAD heart pump

THE MOST WIDELY USED AND EXTENSIVELY INVESTIGATED LVAD2

The HeartMate II LVAD is indicated in the United States for both target therapy and bridge transplantation. In addition, the HeartMate II LVAD is backed by over 10 years of clinical experience.

More than 27,000 heart failure patients have received the HeartMate II LVAD to date. Many have passed the 5 year milestone in therapy, and some are still in therapy more than 10 years later. These figures provide more than a decade of living evidence that the HeartMate II LVAD offers predictable surgical and clinical performance for better outcomes.

 

HEARTMATE II LVAD HAS MORE THAN 900 CLINICAL OR SCIENTIFIC PUBLICATIONS

Many patients have lived with the HeartMate II LVAD for more than 10 years
Proven Long-Term Patient Outcomes

Research has shown the HeartMate II LVAD:

Reverses and sustains reduction of heart failure symptoms8

Increases patients’ survival rates and quality of life compared with medical management alone9

  • reverses and sustainsreduction of heart failure symptoms
  • Improves patients’ survival rates and quality of life compared to medical treatment alone

HeartMate 2™ yazısı ilk önce Aventin Health üzerinde ortaya çıktı.

]]>